News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
492,172 Results
Type
Article (47549)
Company Profile (37)
Press Release (444586)
Section
Business (139395)
Career Advice (1173)
Deals (26370)
Drug Delivery (81)
Drug Development (63657)
Employer Resources (93)
FDA (12831)
Job Trends (11312)
News (247252)
Policy (25559)
Tag
2024 BioForest Digital (1)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (6)
2024 Biotech Beach Digital (1)
2024 Biotech Beach Standard (1)
2024 Pharm Country Digital (1)
2024 Pharm Country Standard (1)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (1)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 Biotech Bay Standard (1)
2026 Pharm Country Premier (1)
Academia (2714)
Academic (1)
Accelerated approval (2)
Adcomms (14)
Allergies (64)
Alliances (34010)
ALS (64)
Alzheimer's disease (1152)
Antibody-drug conjugate (ADC) (92)
Approvals (12854)
Artificial intelligence (151)
Autoimmune disease (11)
Automation (7)
Bankruptcy (274)
Best Places to Work (9078)
BIOSECURE Act (16)
Biosimilars (78)
Biotechnology (31)
Bladder cancer (51)
Brain cancer (24)
Breast cancer (210)
Cancer (1629)
Cardiovascular disease (125)
Career advice (957)
Career pathing (15)
CAR-T (121)
Cell therapy (311)
Cervical cancer (17)
Clinical research (51672)
Collaboration (575)
Compensation (141)
Complete response letters (23)
COVID-19 (2348)
CRISPR (26)
C-suite (167)
Cystic fibrosis (72)
Data (1650)
Decentralized trials (1)
Denatured (11)
Depression (30)
Diabetes (198)
Diagnostics (4989)
Digital health (9)
Diversity (7)
Diversity, equity & inclusion (29)
Drug discovery (71)
Drug pricing (76)
Drug shortages (16)
Duchenne muscular dystrophy (70)
Earnings (52616)
Editorial (19)
Employer branding (11)
Employer resources (81)
Events (59376)
Executive appointments (542)
FDA (13738)
Featured Employer (13)
Friedreich's ataxia (1)
Frontotemporal dementia (6)
Funding (487)
Gene editing (69)
Generative AI (13)
Gene therapy (195)
GLP-1 (502)
Government (3474)
Grass and pollen (3)
Guidances (42)
Healthcare (14750)
Huntington's disease (14)
IgA nephropathy (18)
Immunology and inflammation (75)
Indications (25)
Infectious disease (2451)
Inflammatory bowel disease (109)
Inflation Reduction Act (8)
Influenza (40)
Intellectual property (74)
Interviews (189)
IPO (13256)
IRA (27)
Job creations (2545)
Job search strategy (838)
Kidney cancer (9)
Labor market (21)
Layoffs (352)
Leadership (5)
Legal (6370)
Liver cancer (54)
Lung cancer (249)
Lymphoma (110)
Machine learning (1)
Management (25)
Manufacturing (220)
MASH (52)
Medical device (10001)
Medtech (10003)
Mergers & acquisitions (13538)
Metabolic disorders (483)
Multiple sclerosis (60)
NASH (14)
Neurodegenerative disease (63)
Neuropsychiatric disorders (17)
Neuroscience (1529)
NextGen: Class of 2025 (4896)
Non-profit (3554)
Northern California (1758)
Now hiring (17)
Obesity (237)
Opinion (88)
Ovarian cancer (69)
Pain (67)
Pancreatic cancer (67)
Parkinson's disease (104)
Partnered (16)
Patents (169)
Patient recruitment (79)
Peanut (40)
People (44792)
Pharmaceutical (14)
Pharmacy benefit managers (17)
Phase I (15459)
Phase II (22805)
Phase III (17700)
Pipeline (860)
Podcasts (19)
Policy (82)
Postmarket research (1931)
Preclinical (6538)
Press Release (42)
Prostate cancer (77)
Psychedelics (25)
Radiopharmaceuticals (202)
Rare diseases (260)
Real estate (4475)
Recruiting (36)
Regulatory (17337)
Reports (28)
Research institute (2001)
Resumes & cover letters (195)
Rett syndrome (3)
RNA editing (1)
RSV (30)
Schizophrenia (53)
Series A (72)
Series B (43)
Service/supplier (5)
Sickle cell disease (39)
Southern California (1553)
Special edition (10)
Spinal muscular atrophy (118)
Sponsored (20)
Startups (2372)
State (2)
Stomach cancer (8)
Supply chain (40)
The Weekly (7)
United States (15612)
Vaccines (570)
Venture capitalists (18)
Webinars (10)
Weight loss (156)
Women's health (23)
Worklife (4)
Date
Today (17)
Last 7 days (470)
Last 30 days (1910)
Last 365 days (25735)
2025 (5823)
2024 (27209)
2023 (30942)
2022 (38218)
2021 (44311)
2020 (43078)
2019 (34720)
2018 (26749)
2017 (24712)
2016 (22766)
2015 (27275)
2014 (19932)
2013 (16785)
2012 (17894)
2011 (18538)
2010 (16779)
Location
Africa (527)
Alabama (43)
Alaska (6)
Arizona (116)
Arkansas (11)
Asia (29760)
Australia (5119)
California (4005)
Canada (1528)
China (360)
Colorado (206)
Connecticut (208)
Delaware (85)
Europe (63114)
Florida (680)
Georgia (144)
Idaho (40)
Illinois (383)
India (15)
Indiana (227)
Iowa (7)
Japan (114)
Kansas (84)
Kentucky (17)
Louisiana (5)
Maine (48)
Maryland (571)
Massachusetts (2702)
Michigan (159)
Minnesota (220)
Mississippi (2)
Missouri (56)
Montana (26)
Nebraska (14)
Nevada (53)
New Hampshire (55)
New Jersey (1282)
New Mexico (16)
New York (1274)
North Carolina (706)
North Dakota (3)
Northern California (1758)
Ohio (133)
Oklahoma (13)
Oregon (26)
Pennsylvania (964)
Puerto Rico (8)
Rhode Island (19)
South America (790)
South Carolina (14)
South Dakota (1)
Southern California (1553)
Tennessee (82)
Texas (664)
Utah (126)
Virginia (109)
Washington D.C. (44)
Washington State (422)
West Virginia (3)
Wisconsin (26)
492,172 Results for "oregon state university".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
MustGrow Receives Registration Approval for TerraSante(TM) in Oregon State
MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the “Company” or “MustGrow”) is pleased to announce receipt of The State of Oregon Agriculture Fertilizer Registration Certificate
February 6, 2024
·
7 min read
Oregon Health & Science University (OHSU) to utilize RayStation technology for radiation therapy planning
RaySearch Laboratories AB announces that Oregon Health & Science University in the USA has placed an order for the treatment planning system RayStation®*.
October 31, 2023
·
1 min read
Drug Development
ASPIRE-FTD Phase 1/2 Clinical Trial Opens in the U.S. at The Ohio State University Wexner Medical Center
AviadoBio today announced that its Phase 1/2 ASPIRE-FTD clinical trial is now open and recruiting patients in the United States at The Ohio State University.
July 1, 2024
·
7 min read
Business
Skanska signs additional contract to expand hospital in Portland, Oregon, USA, for USD 200M, about SEK 2.1 billion
Skanska has signed an additional contract with Oregon Health & Science University for its Hospital Expansion Project in Portland, Oregon, USA.
December 22, 2023
·
1 min read
Regulatory
Senate Democrats Demand Return of Fired CDC Staff:
Reuters
Democratic senators from Georgia, Oregon, Maryland and New Mexico called the Trump administration’s decision to terminate hundreds of CDC staffers reckless and unfair.
March 20, 2025
·
2 min read
·
Tristan Manalac
Job Trends
Getting Jobs Outside of Major Biopharma Hubs Proves Tough,
BioSpace
Finds
Over 80% of those living outside of biopharma’s biggest hubs, like San Diego or Boston, have a tough time finding work, according to a
BioSpace
LinkedIn poll. Biopharma professionals in Oregon and Connecticut and a
BioSpace
recruitment manager share their insights on this issue.
February 27, 2025
·
6 min read
·
Angela Gabriel
Press Releases
Ryoncil® is Now Available for Purchase in the United States
March 27, 2025
·
6 min read
Lone Star Bio
Oregon Therapeutics & Lantern Pharma Launch Strategic AI Collaboration to Optimize Development of First-In-Class Drug Candidate XCE853 – A Potent Inhibitor of Cancer Metabolism
Lantern Pharma Inc. announced a strategic AI-driven collaboration with French biotechnology company, Oregon Therapeutics to optimize the development of its first-in-class protein disulfide isomerase inhibitor drug candidate XCE853 in novel and targeted cancer indications.
May 6, 2024
·
15 min read
Business
QIAGEN announces partnership with Penn State University to advance microbiome sciences
QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced a first-in-kind collaboration with Penn State University in the United States to create a shared research and education facility for the fast-developing microbiome sciences.
January 25, 2024
·
9 min read
Press Releases
Numinus Approved as a State-Certified Natural Medicine Training Program in Colorado
March 20, 2025
·
3 min read
1 of 49,218
Next
